Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
115 |
1977 |
5.368e-48 |
2.498e-44 |
2 |
PROTEIN PHOSPHORYLATION |
82 |
944 |
1.55e-45 |
3.606e-42 |
3 |
PHOSPHORYLATION |
90 |
1228 |
3.088e-44 |
4.79e-41 |
4 |
INTRACELLULAR SIGNAL TRANSDUCTION |
88 |
1572 |
5.727e-34 |
6.662e-31 |
5 |
REGULATION OF TRANSFERASE ACTIVITY |
68 |
946 |
3.69e-32 |
3.434e-29 |
6 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
88 |
1710 |
3.257e-31 |
2.526e-28 |
7 |
CELL CYCLE |
76 |
1316 |
8.289e-30 |
5.51e-27 |
8 |
REGULATION OF CELL CYCLE |
65 |
949 |
1.872e-29 |
1.089e-26 |
9 |
MITOTIC CELL CYCLE |
58 |
766 |
1.946e-28 |
1.006e-25 |
10 |
CELL CYCLE PHASE TRANSITION |
35 |
255 |
8.68e-26 |
4.039e-23 |
11 |
REGULATION OF KINASE ACTIVITY |
54 |
776 |
1.146e-24 |
4.555e-22 |
12 |
CELL CYCLE PROCESS |
63 |
1081 |
1.175e-24 |
4.555e-22 |
13 |
PROTEIN AUTOPHOSPHORYLATION |
30 |
192 |
6.578e-24 |
2.354e-21 |
14 |
REGULATION OF CELL DEATH |
72 |
1472 |
9.294e-24 |
3.089e-21 |
15 |
CELL CYCLE G2 M PHASE TRANSITION |
26 |
138 |
5.095e-23 |
1.565e-20 |
16 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
61 |
1087 |
5.382e-23 |
1.565e-20 |
17 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
46 |
616 |
2.925e-22 |
8.006e-20 |
18 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
70 |
1492 |
5.034e-22 |
1.301e-19 |
19 |
PEPTIDYL AMINO ACID MODIFICATION |
52 |
841 |
2.053e-21 |
5.027e-19 |
20 |
REGULATION OF CELL CYCLE PROCESS |
43 |
558 |
2.359e-21 |
5.227e-19 |
21 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
72 |
1618 |
2.318e-21 |
5.227e-19 |
22 |
REGULATION OF RESPONSE TO STRESS |
66 |
1468 |
1.006e-19 |
2.099e-17 |
23 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
43 |
616 |
1.038e-19 |
2.099e-17 |
24 |
REGULATION OF ORGANELLE ORGANIZATION |
58 |
1178 |
4.186e-19 |
8.115e-17 |
25 |
CELLULAR RESPONSE TO STRESS |
67 |
1565 |
6.537e-19 |
1.217e-16 |
26 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
75 |
1929 |
7.102e-19 |
1.271e-16 |
27 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
37 |
470 |
9.311e-19 |
1.605e-16 |
28 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
44 |
691 |
1.251e-18 |
2.078e-16 |
29 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
62 |
1381 |
1.86e-18 |
2.824e-16 |
30 |
NEGATIVE REGULATION OF CELL DEATH |
49 |
872 |
1.881e-18 |
2.824e-16 |
31 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
56 |
1135 |
1.771e-18 |
2.824e-16 |
32 |
REGULATION OF MITOTIC CELL CYCLE |
36 |
468 |
6.048e-18 |
8.795e-16 |
33 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
67 |
1656 |
1.232e-17 |
1.737e-15 |
34 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
70 |
1805 |
1.757e-17 |
2.405e-15 |
35 |
CELL DEATH |
51 |
1001 |
2.098e-17 |
2.79e-15 |
36 |
REGULATION OF CELL PROLIFERATION |
63 |
1496 |
2.166e-17 |
2.8e-15 |
37 |
PEPTIDYL SERINE MODIFICATION |
22 |
148 |
2.493e-17 |
3.135e-15 |
38 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
69 |
1791 |
4.535e-17 |
5.553e-15 |
39 |
CELL CYCLE CHECKPOINT |
24 |
194 |
6.514e-17 |
7.772e-15 |
40 |
CELL DIVISION |
34 |
460 |
1.821e-16 |
2.069e-14 |
41 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
29 |
321 |
1.823e-16 |
2.069e-14 |
42 |
NEGATIVE REGULATION OF CELL CYCLE |
33 |
433 |
2.134e-16 |
2.364e-14 |
43 |
POSITIVE REGULATION OF GENE EXPRESSION |
66 |
1733 |
4.756e-16 |
5.146e-14 |
44 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
68 |
1848 |
8.46e-16 |
8.947e-14 |
45 |
RESPONSE TO ENDOGENOUS STIMULUS |
59 |
1450 |
1.373e-15 |
1.42e-13 |
46 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
52 |
1152 |
1.493e-15 |
1.51e-13 |
47 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
60 |
1518 |
2.777e-15 |
2.749e-13 |
48 |
RESPONSE TO HORMONE |
45 |
893 |
3.227e-15 |
3.128e-13 |
49 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
36 |
573 |
3.572e-15 |
3.392e-13 |
50 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
26 |
280 |
3.723e-15 |
3.465e-13 |
51 |
PROTEIN DEPHOSPHORYLATION |
22 |
190 |
5.491e-15 |
5.01e-13 |
52 |
REGULATION OF DNA METABOLIC PROCESS |
28 |
340 |
6.642e-15 |
5.943e-13 |
53 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
28 |
351 |
1.484e-14 |
1.303e-12 |
54 |
RESPONSE TO NITROGEN COMPOUND |
43 |
859 |
1.83e-14 |
1.577e-12 |
55 |
POSITIVE REGULATION OF CELL DEATH |
36 |
605 |
1.881e-14 |
1.591e-12 |
56 |
RESPONSE TO ABIOTIC STIMULUS |
47 |
1024 |
2.362e-14 |
1.963e-12 |
57 |
POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION |
31 |
448 |
2.602e-14 |
2.124e-12 |
58 |
IMMUNE SYSTEM PROCESS |
68 |
1984 |
2.831e-14 |
2.271e-12 |
59 |
POSITIVE REGULATION OF KINASE ACTIVITY |
32 |
482 |
3.047e-14 |
2.403e-12 |
60 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
44 |
917 |
3.867e-14 |
2.949e-12 |
61 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
48 |
1079 |
3.86e-14 |
2.949e-12 |
62 |
DNA INTEGRITY CHECKPOINT |
19 |
146 |
4.841e-14 |
3.633e-12 |
63 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
22 |
214 |
6.623e-14 |
4.892e-12 |
64 |
POSITIVE REGULATION OF CELL COMMUNICATION |
57 |
1532 |
2.105e-13 |
1.507e-11 |
65 |
POSITIVE REGULATION OF CELL CYCLE |
26 |
332 |
2.098e-13 |
1.507e-11 |
66 |
REGULATION OF BINDING |
24 |
283 |
3.299e-13 |
2.326e-11 |
67 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
31 |
498 |
4.393e-13 |
3.051e-11 |
68 |
REGULATION OF PROTEOLYSIS |
37 |
711 |
4.772e-13 |
3.265e-11 |
69 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
28 |
404 |
4.85e-13 |
3.27e-11 |
70 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
39 |
799 |
7.74e-13 |
5.145e-11 |
71 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
53 |
1395 |
7.915e-13 |
5.187e-11 |
72 |
MITOTIC NUCLEAR DIVISION |
26 |
361 |
1.447e-12 |
9.349e-11 |
73 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
55 |
1517 |
1.729e-12 |
1.102e-10 |
74 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
32 |
563 |
2.062e-12 |
1.297e-10 |
75 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
44 |
1036 |
2.54e-12 |
1.555e-10 |
76 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
44 |
1036 |
2.54e-12 |
1.555e-10 |
77 |
CELLULAR RESPONSE TO DNA DAMAGE STIMULUS |
36 |
720 |
3.26e-12 |
1.97e-10 |
78 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
25 |
352 |
5.417e-12 |
3.231e-10 |
79 |
CELL PROLIFERATION |
34 |
672 |
1.004e-11 |
5.914e-10 |
80 |
ACTIVATION OF IMMUNE RESPONSE |
27 |
427 |
1.097e-11 |
6.383e-10 |
81 |
CELL MOTILITY |
38 |
835 |
1.283e-11 |
7.28e-10 |
82 |
LOCALIZATION OF CELL |
38 |
835 |
1.283e-11 |
7.28e-10 |
83 |
REGULATION OF CHROMOSOME ORGANIZATION |
22 |
278 |
1.313e-11 |
7.359e-10 |
84 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
29 |
505 |
1.886e-11 |
1.045e-09 |
85 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
34 |
689 |
1.982e-11 |
1.085e-09 |
86 |
REGULATION OF CATABOLIC PROCESS |
35 |
731 |
2.249e-11 |
1.217e-09 |
87 |
DEPHOSPHORYLATION |
22 |
286 |
2.292e-11 |
1.226e-09 |
88 |
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE |
14 |
96 |
2.319e-11 |
1.226e-09 |
89 |
REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
14 |
97 |
2.679e-11 |
1.401e-09 |
90 |
RESPONSE TO RADIATION |
26 |
413 |
2.982e-11 |
1.542e-09 |
91 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
30 |
552 |
3.23e-11 |
1.651e-09 |
92 |
REGULATION OF RNA STABILITY |
16 |
139 |
3.398e-11 |
1.682e-09 |
93 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
18 |
185 |
3.397e-11 |
1.682e-09 |
94 |
MITOTIC CELL CYCLE CHECKPOINT |
16 |
139 |
3.398e-11 |
1.682e-09 |
95 |
NEGATIVE REGULATION OF GENE EXPRESSION |
52 |
1493 |
3.539e-11 |
1.733e-09 |
96 |
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
17 |
162 |
3.632e-11 |
1.76e-09 |
97 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
38 |
867 |
3.87e-11 |
1.857e-09 |
98 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
14 |
100 |
4.09e-11 |
1.942e-09 |
99 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
24 |
360 |
5.506e-11 |
2.588e-09 |
100 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
25 |
393 |
5.855e-11 |
2.724e-09 |
101 |
REGULATION OF CELLULAR LOCALIZATION |
47 |
1277 |
5.93e-11 |
2.732e-09 |
102 |
REGULATION OF CELL DIVISION |
21 |
272 |
6.201e-11 |
2.829e-09 |
103 |
ORGANELLE FISSION |
28 |
496 |
6.4e-11 |
2.891e-09 |
104 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
24 |
363 |
6.536e-11 |
2.924e-09 |
105 |
CELLULAR RESPONSE TO PEPTIDE |
21 |
274 |
7.11e-11 |
3.151e-09 |
106 |
POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
18 |
196 |
8.899e-11 |
3.906e-09 |
107 |
RESPONSE TO PEPTIDE |
25 |
404 |
1.052e-10 |
4.577e-09 |
108 |
REGULATION OF CELL CYCLE ARREST |
14 |
108 |
1.18e-10 |
5.084e-09 |
109 |
NEUROGENESIS |
49 |
1402 |
1.301e-10 |
5.555e-09 |
110 |
REGULATION OF PROTEIN LOCALIZATION |
39 |
950 |
1.435e-10 |
6.071e-09 |
111 |
CELL CYCLE G1 S PHASE TRANSITION |
14 |
111 |
1.715e-10 |
7.127e-09 |
112 |
G1 S TRANSITION OF MITOTIC CELL CYCLE |
14 |
111 |
1.715e-10 |
7.127e-09 |
113 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
21 |
289 |
1.912e-10 |
7.875e-09 |
114 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
40 |
1008 |
2.216e-10 |
9.044e-09 |
115 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
22 |
323 |
2.404e-10 |
9.727e-09 |
116 |
REGULATION OF INNATE IMMUNE RESPONSE |
23 |
357 |
2.773e-10 |
1.112e-08 |
117 |
ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS |
12 |
77 |
2.875e-10 |
1.143e-08 |
118 |
RESPONSE TO LIPID |
37 |
888 |
2.991e-10 |
1.179e-08 |
119 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
15 |
139 |
3.566e-10 |
1.394e-08 |
120 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
24 |
395 |
3.674e-10 |
1.425e-08 |
121 |
POSITIVE REGULATION OF PROTEOLYSIS |
23 |
363 |
3.846e-10 |
1.479e-08 |
122 |
ERBB SIGNALING PATHWAY |
12 |
79 |
3.916e-10 |
1.494e-08 |
123 |
REGULATION OF IMMUNE RESPONSE |
36 |
858 |
4.43e-10 |
1.676e-08 |
124 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
20 |
274 |
4.857e-10 |
1.823e-08 |
125 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
17 |
191 |
4.905e-10 |
1.826e-08 |
126 |
POSITIVE REGULATION OF INNATE IMMUNE RESPONSE |
19 |
246 |
5.177e-10 |
1.912e-08 |
127 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
19 |
247 |
5.545e-10 |
2.032e-08 |
128 |
REGULATION OF PROTEIN BINDING |
16 |
168 |
5.93e-10 |
2.156e-08 |
129 |
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
9 |
36 |
5.978e-10 |
2.156e-08 |
130 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
15 |
146 |
7.15e-10 |
2.521e-08 |
131 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
15 |
146 |
7.15e-10 |
2.521e-08 |
132 |
RESPONSE TO LIGHT STIMULUS |
20 |
280 |
7.103e-10 |
2.521e-08 |
133 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
28 |
552 |
7.337e-10 |
2.567e-08 |
134 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
16 |
171 |
7.707e-10 |
2.676e-08 |
135 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
17 |
199 |
9.266e-10 |
3.194e-08 |
136 |
RESPONSE TO UV |
14 |
126 |
9.471e-10 |
3.24e-08 |
137 |
REGULATION OF CYTOKINE PRODUCTION |
28 |
563 |
1.141e-09 |
3.874e-08 |
138 |
REGULATION OF MAP KINASE ACTIVITY |
21 |
319 |
1.159e-09 |
3.909e-08 |
139 |
LOCOMOTION |
41 |
1114 |
1.206e-09 |
4.038e-08 |
140 |
RESPONSE TO OXIDATIVE STRESS |
22 |
352 |
1.216e-09 |
4.042e-08 |
141 |
ERBB2 SIGNALING PATHWAY |
9 |
39 |
1.301e-09 |
4.293e-08 |
142 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
31 |
684 |
1.31e-09 |
4.293e-08 |
143 |
ACTIVATION OF INNATE IMMUNE RESPONSE |
17 |
204 |
1.358e-09 |
4.418e-08 |
144 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
24 |
422 |
1.382e-09 |
4.466e-08 |
145 |
REGULATION OF LIGASE ACTIVITY |
14 |
130 |
1.435e-09 |
4.605e-08 |
146 |
RESPONSE TO INSULIN |
17 |
205 |
1.464e-09 |
4.665e-08 |
147 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
19 |
263 |
1.59e-09 |
4.992e-08 |
148 |
POSITIVE REGULATION OF CELL PROLIFERATION |
34 |
814 |
1.598e-09 |
4.992e-08 |
149 |
FC RECEPTOR SIGNALING PATHWAY |
17 |
206 |
1.577e-09 |
4.992e-08 |
150 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
27 |
541 |
2.139e-09 |
6.59e-08 |
151 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
27 |
541 |
2.139e-09 |
6.59e-08 |
152 |
REGULATION OF MAPK CASCADE |
30 |
660 |
2.311e-09 |
7.073e-08 |
153 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
34 |
829 |
2.543e-09 |
7.734e-08 |
154 |
PEPTIDYL TYROSINE MODIFICATION |
16 |
186 |
2.646e-09 |
7.994e-08 |
155 |
REGULATION OF CELL DIFFERENTIATION |
48 |
1492 |
3.22e-09 |
9.667e-08 |
156 |
REGULATION OF NUCLEAR DIVISION |
15 |
163 |
3.327e-09 |
9.84e-08 |
157 |
CYTOSKELETON ORGANIZATION |
34 |
838 |
3.341e-09 |
9.84e-08 |
158 |
REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
9 |
43 |
3.31e-09 |
9.84e-08 |
159 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
23 |
408 |
3.66e-09 |
1.071e-07 |
160 |
DNA METABOLIC PROCESS |
32 |
758 |
3.92e-09 |
1.14e-07 |
161 |
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
16 |
192 |
4.193e-09 |
1.212e-07 |
162 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
51 |
1672 |
5.672e-09 |
1.629e-07 |
163 |
MITOTIC DNA INTEGRITY CHECKPOINT |
12 |
100 |
6.323e-09 |
1.805e-07 |
164 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
14 |
147 |
7.199e-09 |
2.042e-07 |
165 |
REGULATION OF CYTOSKELETON ORGANIZATION |
25 |
502 |
9.117e-09 |
2.571e-07 |
166 |
CHROMOSOME ORGANIZATION |
37 |
1009 |
9.516e-09 |
2.667e-07 |
167 |
REGULATION OF INTRACELLULAR TRANSPORT |
28 |
621 |
9.792e-09 |
2.728e-07 |
168 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
34 |
876 |
1.012e-08 |
2.804e-07 |
169 |
REGULATION OF CELL DEVELOPMENT |
33 |
836 |
1.136e-08 |
3.127e-07 |
170 |
REGULATION OF IMMUNE SYSTEM PROCESS |
45 |
1403 |
1.201e-08 |
3.288e-07 |
171 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
16 |
207 |
1.234e-08 |
3.358e-07 |
172 |
RESPONSE TO EXTERNAL STIMULUS |
53 |
1821 |
1.323e-08 |
3.579e-07 |
173 |
REGULATION OF NEURON DIFFERENTIATION |
26 |
554 |
1.525e-08 |
4.102e-07 |
174 |
RESPONSE TO INORGANIC SUBSTANCE |
24 |
479 |
1.633e-08 |
4.368e-07 |
175 |
REGULATION OF CELL PROJECTION ORGANIZATION |
26 |
558 |
1.764e-08 |
4.691e-07 |
176 |
REGULATION OF TYPE I INTERFERON PRODUCTION |
12 |
111 |
2.094e-08 |
5.536e-07 |
177 |
REGULATION OF DNA REPLICATION |
14 |
161 |
2.321e-08 |
6.101e-07 |
178 |
MITOCHONDRIAL MEMBRANE ORGANIZATION |
11 |
92 |
2.845e-08 |
7.437e-07 |
179 |
G1 DNA DAMAGE CHECKPOINT |
10 |
73 |
3.263e-08 |
8.483e-07 |
180 |
REGULATION OF CELL ADHESION |
27 |
629 |
5.037e-08 |
1.302e-06 |
181 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
41 |
1275 |
5.548e-08 |
1.426e-06 |
182 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
20 |
364 |
6.066e-08 |
1.551e-06 |
183 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
12 |
123 |
6.662e-08 |
1.694e-06 |
184 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
38 |
1142 |
7.614e-08 |
1.925e-06 |
185 |
POSITIVE REGULATION OF CHROMOSOME ORGANIZATION |
13 |
150 |
7.728e-08 |
1.944e-06 |
186 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
20 |
370 |
7.922e-08 |
1.982e-06 |
187 |
REGULATION OF PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
11 |
103 |
9.317e-08 |
2.318e-06 |
188 |
POSITIVE REGULATION OF BINDING |
12 |
127 |
9.515e-08 |
2.343e-06 |
189 |
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
12 |
127 |
9.515e-08 |
2.343e-06 |
190 |
CENTROSOME CYCLE |
8 |
45 |
9.817e-08 |
2.404e-06 |
191 |
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
14 |
181 |
1.016e-07 |
2.475e-06 |
192 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
15 |
213 |
1.217e-07 |
2.95e-06 |
193 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
14 |
184 |
1.246e-07 |
3.005e-06 |
194 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
11 |
106 |
1.255e-07 |
3.01e-06 |
195 |
REGULATION OF CHROMOSOME SEGREGATION |
10 |
85 |
1.435e-07 |
3.407e-06 |
196 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
10 |
85 |
1.435e-07 |
3.407e-06 |
197 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
29 |
750 |
1.463e-07 |
3.457e-06 |
198 |
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION |
20 |
387 |
1.639e-07 |
3.851e-06 |
199 |
CELLULAR RESPONSE TO UV |
9 |
66 |
1.678e-07 |
3.903e-06 |
200 |
RESPONSE TO HYDROGEN PEROXIDE |
11 |
109 |
1.675e-07 |
3.903e-06 |
201 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
16 |
250 |
1.714e-07 |
3.969e-06 |
202 |
PROTEIN LOCALIZATION |
50 |
1805 |
1.752e-07 |
4.03e-06 |
203 |
G2 DNA DAMAGE CHECKPOINT |
7 |
33 |
1.758e-07 |
4.03e-06 |
204 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
10 |
87 |
1.794e-07 |
4.092e-06 |
205 |
POSITIVE REGULATION OF LIGASE ACTIVITY |
11 |
110 |
1.84e-07 |
4.155e-06 |
206 |
RESPONSE TO CYTOKINE |
28 |
714 |
1.831e-07 |
4.155e-06 |
207 |
REGULATION OF TELOMERE MAINTENANCE |
9 |
67 |
1.916e-07 |
4.307e-06 |
208 |
REGULATION OF PROTEIN STABILITY |
15 |
221 |
1.968e-07 |
4.402e-06 |
209 |
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
10 |
88 |
2.001e-07 |
4.455e-06 |
210 |
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING |
8 |
50 |
2.313e-07 |
5.124e-06 |
211 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
23 |
514 |
2.516e-07 |
5.548e-06 |
212 |
RESPONSE TO ALCOHOL |
19 |
362 |
2.66e-07 |
5.838e-06 |
213 |
POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION |
9 |
70 |
2.818e-07 |
6.127e-06 |
214 |
REGULATION OF MEMBRANE PERMEABILITY |
9 |
70 |
2.818e-07 |
6.127e-06 |
215 |
DNA REPAIR |
22 |
480 |
3.092e-07 |
6.691e-06 |
216 |
REGULATION OF CYTOPLASMIC TRANSPORT |
22 |
481 |
3.203e-07 |
6.9e-06 |
217 |
FC EPSILON RECEPTOR SIGNALING PATHWAY |
12 |
142 |
3.246e-07 |
6.96e-06 |
218 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
19 |
370 |
3.715e-07 |
7.93e-06 |
219 |
REGULATION OF HOMEOSTATIC PROCESS |
21 |
447 |
3.878e-07 |
8.24e-06 |
220 |
CELL DEVELOPMENT |
42 |
1426 |
4.101e-07 |
8.674e-06 |
221 |
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION |
10 |
96 |
4.569e-07 |
9.62e-06 |
222 |
POSITIVE REGULATION OF CELL ADHESION |
19 |
376 |
4.744e-07 |
9.943e-06 |
223 |
SISTER CHROMATID SEGREGATION |
13 |
176 |
4.976e-07 |
1.038e-05 |
224 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
26 |
662 |
5.023e-07 |
1.039e-05 |
225 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
26 |
662 |
5.023e-07 |
1.039e-05 |
226 |
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
12 |
148 |
5.082e-07 |
1.039e-05 |
227 |
DEFENSE RESPONSE |
38 |
1231 |
5.052e-07 |
1.039e-05 |
228 |
PROTEASOMAL PROTEIN CATABOLIC PROCESS |
16 |
271 |
5.092e-07 |
1.039e-05 |
229 |
RESPONSE TO STEROID HORMONE |
22 |
497 |
5.564e-07 |
1.126e-05 |
230 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
10 |
98 |
5.547e-07 |
1.126e-05 |
231 |
REGULATION OF CENTROSOME CYCLE |
7 |
39 |
5.926e-07 |
1.194e-05 |
232 |
REGULATION OF DEFENSE RESPONSE |
28 |
759 |
6.261e-07 |
1.246e-05 |
233 |
SPINDLE CHECKPOINT |
6 |
25 |
6.269e-07 |
1.246e-05 |
234 |
HISTONE PHOSPHORYLATION |
6 |
25 |
6.269e-07 |
1.246e-05 |
235 |
REGULATION OF MICROTUBULE BASED PROCESS |
15 |
243 |
6.642e-07 |
1.315e-05 |
236 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
12 |
152 |
6.771e-07 |
1.335e-05 |
237 |
NEURON PROJECTION DEVELOPMENT |
23 |
545 |
6.979e-07 |
1.37e-05 |
238 |
LYMPHOCYTE COSTIMULATION |
9 |
78 |
7.224e-07 |
1.412e-05 |
239 |
REGULATION OF GROWTH |
25 |
633 |
7.615e-07 |
1.483e-05 |
240 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
33 |
1004 |
7.917e-07 |
1.535e-05 |
241 |
REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
18 |
354 |
8.755e-07 |
1.69e-05 |
242 |
POSITIVE REGULATION OF NUCLEASE ACTIVITY |
5 |
15 |
9.286e-07 |
1.785e-05 |
243 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
41 |
1423 |
1.014e-06 |
1.942e-05 |
244 |
HIPPO SIGNALING |
6 |
27 |
1.025e-06 |
1.955e-05 |
245 |
REGULATION OF TRANSPORT |
48 |
1804 |
1.043e-06 |
1.982e-05 |
246 |
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
10 |
106 |
1.153e-06 |
2.18e-05 |
247 |
REGULATION OF DEVELOPMENTAL GROWTH |
16 |
289 |
1.193e-06 |
2.238e-05 |
248 |
APOPTOTIC SIGNALING PATHWAY |
16 |
289 |
1.193e-06 |
2.238e-05 |
249 |
MICROTUBULE ORGANIZING CENTER ORGANIZATION |
9 |
84 |
1.363e-06 |
2.548e-05 |
250 |
LEUKOCYTE MIGRATION |
15 |
259 |
1.48e-06 |
2.754e-05 |
251 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
19 |
406 |
1.497e-06 |
2.774e-05 |
252 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
13 |
195 |
1.589e-06 |
2.934e-05 |
253 |
RESPONSE TO METAL ION |
17 |
333 |
1.68e-06 |
3.081e-05 |
254 |
CELLULAR RESPONSE TO RADIATION |
11 |
137 |
1.682e-06 |
3.081e-05 |
255 |
NEGATIVE REGULATION OF DNA METABOLIC PROCESS |
10 |
111 |
1.763e-06 |
3.216e-05 |
256 |
RHYTHMIC PROCESS |
16 |
298 |
1.78e-06 |
3.236e-05 |
257 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
47 |
1784 |
1.821e-06 |
3.296e-05 |
258 |
IMMUNE SYSTEM DEVELOPMENT |
23 |
582 |
2.132e-06 |
3.845e-05 |
259 |
REGULATION OF SISTER CHROMATID SEGREGATION |
8 |
67 |
2.326e-06 |
4.178e-05 |
260 |
REGULATION OF CELL CELL ADHESION |
18 |
380 |
2.399e-06 |
4.293e-05 |
261 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
27 |
767 |
2.441e-06 |
4.352e-05 |
262 |
CELLULAR RESPONSE TO LIGHT STIMULUS |
9 |
91 |
2.684e-06 |
4.766e-05 |
263 |
RIBOSOME BIOGENESIS |
16 |
308 |
2.729e-06 |
4.828e-05 |
264 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
20 |
465 |
2.867e-06 |
5.053e-05 |
265 |
RESPONSE TO IONIZING RADIATION |
11 |
145 |
2.936e-06 |
5.135e-05 |
266 |
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
11 |
145 |
2.936e-06 |
5.135e-05 |
267 |
REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY |
7 |
49 |
2.965e-06 |
5.167e-05 |
268 |
MICROTUBULE CYTOSKELETON ORGANIZATION |
17 |
348 |
3.047e-06 |
5.29e-05 |
269 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
10 |
118 |
3.08e-06 |
5.327e-05 |
270 |
POSITIVE REGULATION OF CELL ACTIVATION |
16 |
311 |
3.091e-06 |
5.327e-05 |
271 |
TUBE DEVELOPMENT |
22 |
552 |
3.125e-06 |
5.365e-05 |
272 |
T CELL RECEPTOR SIGNALING PATHWAY |
11 |
146 |
3.139e-06 |
5.37e-05 |
273 |
REGULATION OF DNA BINDING |
9 |
93 |
3.221e-06 |
5.489e-05 |
274 |
DNA REPLICATION |
13 |
208 |
3.255e-06 |
5.527e-05 |
275 |
MACROMOLECULE CATABOLIC PROCESS |
30 |
926 |
3.502e-06 |
5.925e-05 |
276 |
REGULATION OF DNA BIOSYNTHETIC PROCESS |
9 |
94 |
3.522e-06 |
5.938e-05 |
277 |
SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND |
6 |
33 |
3.595e-06 |
6.018e-05 |
278 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
6 |
33 |
3.595e-06 |
6.018e-05 |
279 |
ENERGY RESERVE METABOLIC PROCESS |
8 |
72 |
4.037e-06 |
6.733e-05 |
280 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
13 |
213 |
4.225e-06 |
7.021e-05 |
281 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
44 |
1676 |
4.524e-06 |
7.491e-05 |
282 |
REPRODUCTION |
37 |
1297 |
4.611e-06 |
7.608e-05 |
283 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
8 |
74 |
4.972e-06 |
8.175e-05 |
284 |
TUBE MORPHOGENESIS |
16 |
323 |
5.011e-06 |
8.21e-05 |
285 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
7 |
53 |
5.092e-06 |
8.313e-05 |
286 |
REGULATION OF GLYCOGEN METABOLIC PROCESS |
6 |
35 |
5.157e-06 |
8.389e-05 |
287 |
REGULATION OF MITOCHONDRION ORGANIZATION |
13 |
218 |
5.444e-06 |
8.825e-05 |
288 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
38 |
1360 |
5.462e-06 |
8.825e-05 |
289 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
17 |
365 |
5.748e-06 |
9.255e-05 |
290 |
INNATE IMMUNE RESPONSE |
23 |
619 |
5.91e-06 |
9.482e-05 |
291 |
CELL PROJECTION ORGANIZATION |
29 |
902 |
5.97e-06 |
9.546e-05 |
292 |
REGULATION OF CELLULAR RESPONSE TO HEAT |
8 |
76 |
6.084e-06 |
9.695e-05 |
293 |
EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
7 |
55 |
6.558e-06 |
0.0001038 |
294 |
NEGATIVE REGULATION OF DNA REPLICATION |
7 |
55 |
6.558e-06 |
0.0001038 |
295 |
NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
10 |
131 |
7.874e-06 |
0.0001234 |
296 |
NEGATIVE REGULATION OF BINDING |
10 |
131 |
7.874e-06 |
0.0001234 |
297 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
10 |
131 |
7.874e-06 |
0.0001234 |
298 |
NEGATIVE REGULATION OF PROTEIN BINDING |
8 |
79 |
8.142e-06 |
0.0001267 |
299 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
9 |
104 |
8.134e-06 |
0.0001267 |
300 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
11 |
162 |
8.548e-06 |
0.0001326 |
301 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
14 |
263 |
8.767e-06 |
0.0001355 |
302 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
13 |
228 |
8.846e-06 |
0.0001358 |
303 |
NUCLEAR CHROMOSOME SEGREGATION |
13 |
228 |
8.846e-06 |
0.0001358 |
304 |
CELLULAR GLUCAN METABOLIC PROCESS |
7 |
58 |
9.402e-06 |
0.0001434 |
305 |
GLUCAN METABOLIC PROCESS |
7 |
58 |
9.402e-06 |
0.0001434 |
306 |
REGULATION OF NUCLEASE ACTIVITY |
5 |
23 |
9.562e-06 |
0.0001454 |
307 |
CELLULAR MACROMOLECULE LOCALIZATION |
35 |
1234 |
9.733e-06 |
0.0001475 |
308 |
REGULATION OF FIBROBLAST PROLIFERATION |
8 |
81 |
9.818e-06 |
0.0001483 |
309 |
PEPTIDYL TYROSINE AUTOPHOSPHORYLATION |
6 |
39 |
9.927e-06 |
0.0001495 |
310 |
NEURON DEVELOPMENT |
24 |
687 |
1.034e-05 |
0.0001552 |
311 |
POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS |
7 |
59 |
1.055e-05 |
0.0001579 |
312 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
23 |
643 |
1.093e-05 |
0.000163 |
313 |
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION |
11 |
167 |
1.141e-05 |
0.000169 |
314 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
11 |
167 |
1.141e-05 |
0.000169 |
315 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
34 |
1192 |
1.175e-05 |
0.0001736 |
316 |
REGULATION OF MONOOXYGENASE ACTIVITY |
7 |
60 |
1.181e-05 |
0.000174 |
317 |
RESPONSE TO BIOTIC STIMULUS |
28 |
886 |
1.198e-05 |
0.0001759 |
318 |
POSITIVE REGULATION OF TRANSPORT |
29 |
936 |
1.203e-05 |
0.000176 |
319 |
POSITIVE REGULATION OF MAPK CASCADE |
19 |
470 |
1.229e-05 |
0.0001793 |
320 |
CHROMOSOME SEGREGATION |
14 |
272 |
1.282e-05 |
0.0001864 |
321 |
RESPONSE TO OXYGEN LEVELS |
15 |
311 |
1.362e-05 |
0.0001962 |
322 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
22 |
606 |
1.361e-05 |
0.0001962 |
323 |
RESPONSE TO DRUG |
18 |
431 |
1.354e-05 |
0.0001962 |
324 |
SISTER CHROMATID COHESION |
9 |
111 |
1.383e-05 |
0.0001987 |
325 |
POSITIVE REGULATION OF GROWTH |
13 |
238 |
1.4e-05 |
0.0002004 |
326 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
8 |
85 |
1.405e-05 |
0.0002006 |
327 |
EPITHELIUM DEVELOPMENT |
29 |
945 |
1.438e-05 |
0.0002046 |
328 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
11 |
172 |
1.506e-05 |
0.0002136 |
329 |
POSITIVE REGULATION OF DNA REPLICATION |
8 |
86 |
1.532e-05 |
0.0002167 |
330 |
POSITIVE REGULATION OF DNA BINDING |
6 |
42 |
1.545e-05 |
0.0002179 |
331 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
18 |
437 |
1.63e-05 |
0.0002291 |
332 |
RAS PROTEIN SIGNAL TRANSDUCTION |
10 |
143 |
1.703e-05 |
0.0002387 |
333 |
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE |
4 |
13 |
1.765e-05 |
0.0002466 |
334 |
HOMEOSTASIS OF NUMBER OF CELLS |
11 |
175 |
1.771e-05 |
0.0002467 |
335 |
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS |
6 |
43 |
1.777e-05 |
0.0002468 |
336 |
ESTABLISHMENT OF CELL POLARITY |
8 |
88 |
1.816e-05 |
0.0002504 |
337 |
REGULATION OF CYTOKINESIS |
7 |
64 |
1.819e-05 |
0.0002504 |
338 |
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
8 |
88 |
1.816e-05 |
0.0002504 |
339 |
RESPONSE TO ACID CHEMICAL |
15 |
319 |
1.836e-05 |
0.0002519 |
340 |
NEGATIVE REGULATION OF MAPK CASCADE |
10 |
145 |
1.922e-05 |
0.0002623 |
341 |
REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
10 |
145 |
1.922e-05 |
0.0002623 |
342 |
IMMUNE EFFECTOR PROCESS |
19 |
486 |
1.956e-05 |
0.0002661 |
343 |
MITOCHONDRIAL TRANSPORT |
11 |
177 |
1.969e-05 |
0.0002671 |
344 |
REGULATION OF OXIDOREDUCTASE ACTIVITY |
8 |
90 |
2.142e-05 |
0.0002897 |
345 |
PROTEIN CATABOLIC PROCESS |
21 |
579 |
2.179e-05 |
0.0002938 |
346 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
17 |
408 |
2.428e-05 |
0.0003262 |
347 |
MACROMOLECULAR COMPLEX ASSEMBLY |
37 |
1398 |
2.433e-05 |
0.0003262 |
348 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
27 |
872 |
2.476e-05 |
0.0003311 |
349 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
26 |
823 |
2.514e-05 |
0.0003351 |
350 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
12 |
216 |
2.538e-05 |
0.0003375 |
351 |
NEGATIVE REGULATION OF PROTEOLYSIS |
15 |
329 |
2.628e-05 |
0.0003484 |
352 |
NEGATIVE REGULATION OF CHROMOSOME SEGREGATION |
5 |
28 |
2.649e-05 |
0.0003492 |
353 |
PEPTIDYL THREONINE MODIFICATION |
6 |
46 |
2.643e-05 |
0.0003492 |
354 |
POSITIVE REGULATION OF TELOMERE MAINTENANCE |
6 |
47 |
2.997e-05 |
0.0003939 |
355 |
REGULATION OF CELL CYCLE CHECKPOINT |
5 |
29 |
3.168e-05 |
0.0004129 |
356 |
REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
5 |
29 |
3.168e-05 |
0.0004129 |
357 |
POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
5 |
29 |
3.168e-05 |
0.0004129 |
358 |
FC GAMMA RECEPTOR SIGNALING PATHWAY |
8 |
95 |
3.177e-05 |
0.000413 |
359 |
CELLULAR RESPONSE TO NITRIC OXIDE |
4 |
15 |
3.302e-05 |
0.000428 |
360 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
15 |
337 |
3.466e-05 |
0.000448 |
361 |
CELLULAR RESPONSE TO INORGANIC SUBSTANCE |
10 |
156 |
3.611e-05 |
0.0004654 |
362 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
21 |
602 |
3.845e-05 |
0.0004942 |
363 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
19 |
513 |
4.085e-05 |
0.0005236 |
364 |
POSITIVE REGULATION OF PROTEIN BINDING |
7 |
73 |
4.323e-05 |
0.0005481 |
365 |
LYMPHOCYTE HOMEOSTASIS |
6 |
50 |
4.294e-05 |
0.0005481 |
366 |
REGULATION OF ORGAN GROWTH |
7 |
73 |
4.323e-05 |
0.0005481 |
367 |
CELLULAR COMPONENT DISASSEMBLY |
19 |
515 |
4.305e-05 |
0.0005481 |
368 |
RNA STABILIZATION |
5 |
31 |
4.438e-05 |
0.0005611 |
369 |
RESPONSE TO WOUNDING |
20 |
563 |
4.588e-05 |
0.000577 |
370 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
9 |
129 |
4.588e-05 |
0.000577 |
371 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
14 |
307 |
4.871e-05 |
0.000611 |
372 |
MICROTUBULE BASED PROCESS |
19 |
522 |
5.157e-05 |
0.0006451 |
373 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS |
5 |
32 |
5.204e-05 |
0.0006492 |
374 |
REGULATION OF CELL GROWTH |
16 |
391 |
5.228e-05 |
0.0006504 |
375 |
RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN |
10 |
163 |
5.244e-05 |
0.0006507 |
376 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
11 |
197 |
5.27e-05 |
0.0006522 |
377 |
RESPONSE TO ENDOPLASMIC RETICULUM STRESS |
12 |
233 |
5.317e-05 |
0.0006563 |
378 |
REGULATION OF PEPTIDASE ACTIVITY |
16 |
392 |
5.389e-05 |
0.0006633 |
379 |
POSITIVE REGULATION OF CELL DIVISION |
9 |
132 |
5.493e-05 |
0.0006744 |
380 |
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
8 |
103 |
5.688e-05 |
0.0006965 |
381 |
NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
6 |
53 |
6.007e-05 |
0.0007336 |
382 |
POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING |
5 |
33 |
6.07e-05 |
0.0007374 |
383 |
CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY |
5 |
33 |
6.07e-05 |
0.0007374 |
384 |
REGULATION OF INTERLEUKIN 6 PRODUCTION |
8 |
104 |
6.095e-05 |
0.0007385 |
385 |
REGULATION OF CELL ACTIVATION |
18 |
484 |
6.19e-05 |
0.0007462 |
386 |
PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
9 |
134 |
6.177e-05 |
0.0007462 |
387 |
RIBONUCLEOPROTEIN COMPLEX BIOGENESIS |
17 |
440 |
6.228e-05 |
0.0007469 |
388 |
TISSUE DEVELOPMENT |
38 |
1518 |
6.225e-05 |
0.0007469 |
389 |
NUCLEAR TRANSPORT |
15 |
355 |
6.261e-05 |
0.0007489 |
390 |
REGULATION OF ERK1 AND ERK2 CASCADE |
12 |
238 |
6.522e-05 |
0.0007782 |
391 |
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
26 |
873 |
6.714e-05 |
0.000799 |
392 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
10 |
168 |
6.765e-05 |
0.0008009 |
393 |
REGULATION OF AXONOGENESIS |
10 |
168 |
6.765e-05 |
0.0008009 |
394 |
MORPHOGENESIS OF AN EPITHELIUM |
16 |
400 |
6.837e-05 |
0.0008059 |
395 |
NEURON DIFFERENTIATION |
26 |
874 |
6.841e-05 |
0.0008059 |
396 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
27 |
926 |
6.912e-05 |
0.0008122 |
397 |
T CELL HOMEOSTASIS |
5 |
34 |
7.042e-05 |
0.0008232 |
398 |
NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION |
5 |
34 |
7.042e-05 |
0.0008232 |
399 |
RESPONSE TO PLATELET DERIVED GROWTH FACTOR |
4 |
18 |
7.18e-05 |
0.0008352 |
400 |
REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY |
4 |
18 |
7.18e-05 |
0.0008352 |
401 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
13 |
279 |
7.286e-05 |
0.0008455 |
402 |
CIRCADIAN RHYTHM |
9 |
137 |
7.336e-05 |
0.000847 |
403 |
ACTIVATION OF MAPK ACTIVITY |
9 |
137 |
7.336e-05 |
0.000847 |
404 |
RESPONSE TO RETINOIC ACID |
8 |
107 |
7.461e-05 |
0.0008593 |
405 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
9 |
138 |
7.761e-05 |
0.0008894 |
406 |
PLACENTA DEVELOPMENT |
9 |
138 |
7.761e-05 |
0.0008894 |
407 |
POLYSACCHARIDE METABOLIC PROCESS |
7 |
80 |
7.807e-05 |
0.0008926 |
408 |
POSITIVE REGULATION OF CELL CELL ADHESION |
12 |
243 |
7.956e-05 |
0.0009074 |
409 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
13 |
282 |
8.117e-05 |
0.0009226 |
410 |
NEURON APOPTOTIC PROCESS |
5 |
35 |
8.129e-05 |
0.0009226 |
411 |
REGULATION OF CELL SIZE |
10 |
172 |
8.236e-05 |
0.0009325 |
412 |
PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY |
8 |
109 |
8.506e-05 |
0.0009606 |
413 |
REGULATION OF CELL SUBSTRATE ADHESION |
10 |
173 |
8.644e-05 |
0.0009739 |
414 |
DENDRITIC SPINE DEVELOPMENT |
4 |
19 |
9.003e-05 |
0.001009 |
415 |
CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES |
4 |
19 |
9.003e-05 |
0.001009 |
416 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
9 |
141 |
9.161e-05 |
0.001023 |
417 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
24 |
788 |
9.193e-05 |
0.001023 |
418 |
CIRCULATORY SYSTEM DEVELOPMENT |
24 |
788 |
9.193e-05 |
0.001023 |
419 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
23 |
740 |
9.576e-05 |
0.001063 |
420 |
CELLULAR RESPONSE TO LIPID |
17 |
457 |
9.881e-05 |
0.001092 |
421 |
NIK NF KAPPAB SIGNALING |
7 |
83 |
9.875e-05 |
0.001092 |
422 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
9 |
143 |
0.0001021 |
0.001126 |
423 |
REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
6 |
59 |
0.0001105 |
0.001216 |
424 |
PROTEIN ADP RIBOSYLATION |
4 |
20 |
0.0001114 |
0.001222 |
425 |
REGULATION OF NEURON DEATH |
12 |
252 |
0.0001123 |
0.001229 |
426 |
LEUKOCYTE DIFFERENTIATION |
13 |
292 |
0.0001151 |
0.001257 |
427 |
PROTEIN LOCALIZATION TO ORGANELLE |
19 |
556 |
0.0001182 |
0.001288 |
428 |
RESPONSE TO ESTRADIOL |
9 |
146 |
0.0001196 |
0.001301 |
429 |
NEGATIVE REGULATION OF CELL DIVISION |
6 |
60 |
0.0001215 |
0.001315 |
430 |
LEUKOCYTE HOMEOSTASIS |
6 |
60 |
0.0001215 |
0.001315 |
431 |
PROTEIN SUMOYLATION |
8 |
115 |
0.0001239 |
0.001338 |
432 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
11 |
218 |
0.0001303 |
0.001403 |
433 |
B CELL HOMEOSTASIS |
4 |
21 |
0.0001362 |
0.001454 |
434 |
REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION |
4 |
21 |
0.0001362 |
0.001454 |
435 |
NEGATIVE REGULATION OF ORGAN GROWTH |
4 |
21 |
0.0001362 |
0.001454 |
436 |
RESPONSE TO NITRIC OXIDE |
4 |
21 |
0.0001362 |
0.001454 |
437 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
15 |
381 |
0.0001371 |
0.00146 |
438 |
HEAD DEVELOPMENT |
22 |
709 |
0.0001395 |
0.001482 |
439 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
11 |
220 |
0.0001412 |
0.001496 |
440 |
MYELOID CELL HOMEOSTASIS |
7 |
88 |
0.000143 |
0.001512 |
441 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
37 |
1527 |
0.0001523 |
0.001607 |
442 |
MEIOTIC CELL CYCLE |
10 |
186 |
0.0001571 |
0.00165 |
443 |
RESPONSE TO GROWTH FACTOR |
17 |
475 |
0.0001569 |
0.00165 |
444 |
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
7 |
90 |
0.0001646 |
0.001721 |
445 |
REGULATION OF CELL MATRIX ADHESION |
7 |
90 |
0.0001646 |
0.001721 |
446 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
13 |
303 |
0.0001659 |
0.001731 |
447 |
AGING |
12 |
264 |
0.0001734 |
0.001805 |
448 |
MYELOID CELL DIFFERENTIATION |
10 |
189 |
0.000179 |
0.001859 |
449 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
27 |
983 |
0.0001843 |
0.00191 |
450 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
9 |
156 |
0.0001975 |
0.002042 |
451 |
WNT SIGNALING PATHWAY |
14 |
351 |
2e-04 |
0.002063 |
452 |
PROTEOLYSIS |
31 |
1208 |
0.0002039 |
0.002099 |
453 |
INTRACELLULAR PROTEIN TRANSPORT |
23 |
781 |
0.0002105 |
0.002162 |
454 |
RESPONSE TO PURINE CONTAINING COMPOUND |
9 |
158 |
0.0002173 |
0.002227 |
455 |
REGULATION OF TELOMERASE ACTIVITY |
5 |
43 |
0.0002216 |
0.002266 |
456 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
6 |
67 |
0.0002246 |
0.002292 |
457 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
8 |
126 |
0.0002331 |
0.002373 |
458 |
NEURON PROJECTION MORPHOGENESIS |
15 |
402 |
0.0002449 |
0.002488 |
459 |
EMBRYO DEVELOPMENT |
25 |
894 |
0.0002458 |
0.002491 |
460 |
REGULATION OF INTERFERON BETA PRODUCTION |
5 |
44 |
0.0002474 |
0.002503 |
461 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
11 |
236 |
0.0002597 |
0.002621 |
462 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
9 |
162 |
0.0002618 |
0.002637 |
463 |
MITOTIC SPINDLE ORGANIZATION |
6 |
69 |
0.0002641 |
0.002654 |
464 |
CELLULAR COMPONENT MORPHOGENESIS |
25 |
900 |
0.0002718 |
0.002725 |
465 |
CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT |
4 |
25 |
0.0002765 |
0.002749 |
466 |
PROTEIN LOCALIZATION TO CHROMOSOME |
5 |
45 |
0.0002755 |
0.002749 |
467 |
POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION |
4 |
25 |
0.0002765 |
0.002749 |
468 |
POSITIVE REGULATION OF CHROMOSOME SEGREGATION |
4 |
25 |
0.0002765 |
0.002749 |
469 |
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
7 |
98 |
0.0002794 |
0.002772 |
470 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
7 |
99 |
0.0002974 |
0.002944 |
471 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
23 |
801 |
0.0003017 |
0.00298 |
472 |
RESPONSE TO COCAINE |
5 |
46 |
0.0003058 |
0.003008 |
473 |
NEGATIVE REGULATION OF NUCLEAR DIVISION |
5 |
46 |
0.0003058 |
0.003008 |
474 |
REGULATION OF MITOTIC SPINDLE CHECKPOINT |
3 |
11 |
0.0003243 |
0.00317 |
475 |
FEMALE MEIOTIC DIVISION |
4 |
26 |
0.0003234 |
0.00317 |
476 |
REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT |
3 |
11 |
0.0003243 |
0.00317 |
477 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
27 |
1021 |
0.0003361 |
0.003272 |
478 |
REGULATION OF EXTENT OF CELL GROWTH |
7 |
101 |
0.0003362 |
0.003272 |
479 |
NEURON DEATH |
5 |
47 |
0.0003387 |
0.00329 |
480 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
8 |
135 |
0.0003722 |
0.003608 |
481 |
RESPONSE TO VIRUS |
11 |
247 |
0.0003828 |
0.003703 |
482 |
HEART DEVELOPMENT |
16 |
466 |
0.0003867 |
0.003733 |
483 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
14 |
375 |
0.0003907 |
0.003756 |
484 |
NEGATIVE REGULATION OF NEURON DEATH |
9 |
171 |
0.0003901 |
0.003756 |
485 |
RESPONSE TO CAMP |
7 |
104 |
0.0004019 |
0.003855 |
486 |
RIBOSOMAL LARGE SUBUNIT BIOGENESIS |
5 |
49 |
0.0004123 |
0.003947 |
487 |
REGULATION OF DNA REPAIR |
6 |
75 |
0.000416 |
0.003975 |
488 |
STRIATED MUSCLE CELL DIFFERENTIATION |
9 |
173 |
0.0004246 |
0.004049 |
489 |
X3 UTR MEDIATED MRNA STABILIZATION |
3 |
12 |
0.0004283 |
0.004067 |
490 |
REPLICATIVE SENESCENCE |
3 |
12 |
0.0004283 |
0.004067 |
491 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY |
4 |
28 |
0.0004341 |
0.004081 |
492 |
POSITIVE REGULATION OF TELOMERASE ACTIVITY |
4 |
28 |
0.0004341 |
0.004081 |
493 |
REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY |
4 |
28 |
0.0004341 |
0.004081 |
494 |
REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE |
4 |
28 |
0.0004341 |
0.004081 |
495 |
GENERATION OF PRECURSOR METABOLITES AND ENERGY |
12 |
292 |
0.0004342 |
0.004081 |
496 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
16 |
472 |
0.0004446 |
0.004171 |
497 |
RESPONSE TO ORGANOPHOSPHORUS |
8 |
139 |
0.0004527 |
0.004235 |
498 |
RESPONSE TO GAMMA RADIATION |
5 |
50 |
0.0004533 |
0.004235 |
499 |
REGULATION OF CELLULAR COMPONENT SIZE |
13 |
337 |
0.0004617 |
0.004288 |
500 |
CELLULAR RESPONSE TO ACID CHEMICAL |
9 |
175 |
0.0004617 |
0.004288 |
501 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
9 |
175 |
0.0004617 |
0.004288 |
502 |
RESPONSE TO CORTICOSTEROID |
9 |
176 |
0.0004812 |
0.00446 |
503 |
RESPONSE TO AMMONIUM ION |
5 |
51 |
0.0004974 |
0.004601 |
504 |
NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY |
4 |
29 |
0.0004985 |
0.004602 |
505 |
DNA RECOMBINATION |
10 |
215 |
0.0005002 |
0.004609 |
506 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
12 |
297 |
0.0005051 |
0.004644 |
507 |
REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION |
9 |
178 |
0.0005223 |
0.004793 |
508 |
ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS |
10 |
217 |
0.0005377 |
0.004925 |
509 |
DENDRITE DEVELOPMENT |
6 |
79 |
0.0005502 |
0.005012 |
510 |
POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
3 |
13 |
0.0005515 |
0.005012 |
511 |
REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE |
3 |
13 |
0.0005515 |
0.005012 |
512 |
POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION |
3 |
13 |
0.0005515 |
0.005012 |
513 |
PROTEIN UBIQUITINATION |
19 |
629 |
0.0005532 |
0.005017 |
514 |
RESPONSE TO ESTROGEN |
10 |
218 |
0.0005572 |
0.005044 |
515 |
ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY |
4 |
30 |
0.0005694 |
0.005115 |
516 |
POSITIVE REGULATION OF INTERFERON BETA PRODUCTION |
4 |
30 |
0.0005694 |
0.005115 |
517 |
REGULATION OF VASCULAR PERMEABILITY |
4 |
30 |
0.0005694 |
0.005115 |
518 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
4 |
30 |
0.0005694 |
0.005115 |
519 |
CELLULAR CARBOHYDRATE METABOLIC PROCESS |
8 |
144 |
0.0005726 |
0.005133 |
520 |
COVALENT CHROMATIN MODIFICATION |
13 |
345 |
0.0005753 |
0.005148 |
521 |
INSULIN RECEPTOR SIGNALING PATHWAY |
6 |
80 |
0.0005885 |
0.005255 |
522 |
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
5 |
53 |
0.000595 |
0.005304 |
523 |
RESPONSE TO KETONE |
9 |
182 |
0.000613 |
0.005454 |
524 |
NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION |
10 |
221 |
0.0006196 |
0.005502 |
525 |
REGULATION OF PROTEIN IMPORT |
9 |
183 |
0.0006376 |
0.005651 |
526 |
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL |
5 |
54 |
0.0006489 |
0.00574 |
527 |
GLAND DEVELOPMENT |
14 |
395 |
0.0006525 |
0.005761 |
528 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
25 |
957 |
0.0006686 |
0.005892 |
529 |
JNK CASCADE |
6 |
82 |
0.0006712 |
0.005904 |
530 |
POSITIVE REGULATION OF CELL GROWTH |
8 |
148 |
0.000686 |
0.006022 |
531 |
REGULATION OF SPINDLE CHECKPOINT |
3 |
14 |
0.0006952 |
0.006069 |
532 |
REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION |
3 |
14 |
0.0006952 |
0.006069 |
533 |
POST EMBRYONIC ORGAN DEVELOPMENT |
3 |
14 |
0.0006952 |
0.006069 |
534 |
ACTIN CYTOSKELETON REORGANIZATION |
5 |
55 |
0.0007064 |
0.006143 |
535 |
EXECUTION PHASE OF APOPTOSIS |
5 |
55 |
0.0007064 |
0.006143 |
536 |
REGULATION OF ERBB SIGNALING PATHWAY |
6 |
83 |
0.0007158 |
0.006202 |
537 |
EMBRYONIC PLACENTA DEVELOPMENT |
6 |
83 |
0.0007158 |
0.006202 |
538 |
PATTERNING OF BLOOD VESSELS |
4 |
32 |
0.0007322 |
0.006309 |
539 |
REGULATION OF CENTROSOME DUPLICATION |
4 |
32 |
0.0007322 |
0.006309 |
540 |
CENTROSOME DUPLICATION |
4 |
32 |
0.0007322 |
0.006309 |
541 |
REGULATION OF WNT SIGNALING PATHWAY |
12 |
310 |
0.0007363 |
0.006321 |
542 |
RESPONSE TO INTERLEUKIN 1 |
7 |
115 |
0.0007354 |
0.006321 |
543 |
PROTEIN COMPLEX BIOGENESIS |
28 |
1132 |
0.0007456 |
0.006377 |
544 |
PROTEIN COMPLEX ASSEMBLY |
28 |
1132 |
0.0007456 |
0.006377 |
545 |
IN UTERO EMBRYONIC DEVELOPMENT |
12 |
311 |
0.0007572 |
0.006465 |
546 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
6 |
84 |
0.0007627 |
0.006499 |
547 |
PEPTIDYL LYSINE MODIFICATION |
12 |
312 |
0.0007787 |
0.006624 |
548 |
ACTIN FILAMENT BASED PROCESS |
15 |
450 |
0.0007919 |
0.006724 |
549 |
TOLL LIKE RECEPTOR SIGNALING PATHWAY |
6 |
85 |
0.0008119 |
0.006881 |
550 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
8 |
152 |
0.0008168 |
0.006885 |
551 |
MEIOTIC CELL CYCLE PROCESS |
8 |
152 |
0.0008168 |
0.006885 |
552 |
REGULATION OF GENE EXPRESSION EPIGENETIC |
10 |
229 |
0.0008145 |
0.006885 |
553 |
REGULATION OF PROTEIN EXPORT FROM NUCLEUS |
4 |
33 |
0.0008248 |
0.006928 |
554 |
REGULATION OF BONE RESORPTION |
4 |
33 |
0.0008248 |
0.006928 |
555 |
CIRCADIAN REGULATION OF GENE EXPRESSION |
5 |
57 |
0.0008326 |
0.006961 |
556 |
ENDOTHELIAL CELL MIGRATION |
5 |
57 |
0.0008326 |
0.006961 |
557 |
PHAGOCYTOSIS |
9 |
190 |
0.0008333 |
0.006961 |
558 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
8 |
153 |
0.0008524 |
0.007108 |
559 |
T CELL APOPTOTIC PROCESS |
3 |
15 |
0.0008607 |
0.007165 |
560 |
REGULATION OF CELL MORPHOGENESIS |
17 |
552 |
0.0008709 |
0.007236 |
561 |
REGULATION OF NEURON APOPTOTIC PROCESS |
9 |
192 |
0.0008974 |
0.007443 |
562 |
ER NUCLEUS SIGNALING PATHWAY |
4 |
34 |
0.0009254 |
0.007662 |
563 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
9 |
193 |
0.0009309 |
0.007694 |
564 |
PHOSPHOLIPID METABOLIC PROCESS |
13 |
364 |
0.0009427 |
0.007774 |
565 |
PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS |
7 |
120 |
0.0009457 |
0.007774 |
566 |
REGULATION OF DENDRITE DEVELOPMENT |
7 |
120 |
0.0009457 |
0.007774 |
567 |
SINGLE ORGANISM CELL ADHESION |
15 |
459 |
0.0009666 |
0.007932 |
568 |
REGULATION OF CELL CYCLE G2 M PHASE TRANSITION |
5 |
59 |
0.0009749 |
0.007973 |
569 |
MEIOSIS I |
6 |
88 |
0.0009743 |
0.007973 |
570 |
PHOSPHOLIPID BIOSYNTHETIC PROCESS |
10 |
235 |
0.0009917 |
0.008077 |
571 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
7 |
121 |
0.0009929 |
0.008077 |
572 |
REGULATION OF B CELL ACTIVATION |
7 |
121 |
0.0009929 |
0.008077 |
573 |
B CELL DIFFERENTIATION |
6 |
89 |
0.001034 |
0.00837 |
574 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
6 |
89 |
0.001034 |
0.00837 |
575 |
RESPONSE TO MINERALOCORTICOID |
4 |
35 |
0.001034 |
0.00837 |
576 |
CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN |
7 |
122 |
0.001042 |
0.008418 |
577 |
POSITIVE REGULATION OF TELOMERE CAPPING |
3 |
16 |
0.001049 |
0.008447 |
578 |
DNA LIGATION |
3 |
16 |
0.001049 |
0.008447 |
579 |
MUSCLE CELL DIFFERENTIATION |
10 |
237 |
0.001057 |
0.008497 |
580 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
9 |
197 |
0.001075 |
0.008627 |
581 |
REGULATION OF JNK CASCADE |
8 |
159 |
0.001093 |
0.008757 |
582 |
REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY |
5 |
61 |
0.001135 |
0.009071 |
583 |
POSITIVE REGULATION OF AXON EXTENSION |
4 |
36 |
0.001152 |
0.009162 |
584 |
POSITIVE REGULATION OF ERBB SIGNALING PATHWAY |
4 |
36 |
0.001152 |
0.009162 |
585 |
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS |
4 |
36 |
0.001152 |
0.009162 |
586 |
MITOTIC SISTER CHROMATID SEGREGATION |
6 |
91 |
0.001161 |
0.009215 |
587 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
9 |
200 |
0.001195 |
0.009473 |
588 |
RESPONSE TO TOXIC SUBSTANCE |
10 |
241 |
0.001199 |
0.00949 |
589 |
WOUND HEALING |
15 |
470 |
0.001223 |
0.009631 |
590 |
REGULATION OF MULTI ORGANISM PROCESS |
15 |
470 |
0.001223 |
0.009631 |
591 |
REGULATION OF TISSUE REMODELING |
5 |
62 |
0.001221 |
0.009631 |
592 |
REGULATION OF ORGAN MORPHOGENESIS |
10 |
242 |
0.001237 |
0.009723 |
593 |
RESPONSE TO ANGIOTENSIN |
3 |
17 |
0.001262 |
0.00987 |
594 |
NEGATIVE REGULATION OF CELL AGING |
3 |
17 |
0.001262 |
0.00987 |
595 |
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING |
3 |
17 |
0.001262 |
0.00987 |
596 |
REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION |
4 |
37 |
0.001279 |
0.009949 |
597 |
ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY |
4 |
37 |
0.001279 |
0.009949 |
598 |
ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY |
4 |
37 |
0.001279 |
0.009949 |
599 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
8 |
163 |
0.001282 |
0.00996 |